Renaissance Technologies - ANACOR PHARMACEUTICALS INC ownership

ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 210 filers reported holding ANACOR PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.50 and the average weighting 0.6%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$5,027,000
-86.2%
94,058
-69.7%
0.01%
-88.5%
Q3 2015$36,544,000
+1265.6%
310,458
+183.9%
0.09%
+1142.9%
Q3 2014$2,676,000
-27.3%
109,358
-47.3%
0.01%
-22.2%
Q2 2014$3,680,000
+462.7%
207,578
+534.8%
0.01%
+350.0%
Q1 2014$654,000
-63.2%
32,700
-69.1%
0.00%
-50.0%
Q4 2013$1,775,000105,8000.00%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,067,892$125,702,00041.75%
VHCP Management, LLC 1,178,474$138,718,00035.56%
Palo Alto Investors LP 2,579,154$303,592,00014.60%
Baker Brothers Advisors 4,135,412$486,779,0004.50%
APIS CAPITAL ADVISORS, LLC 23,000$2,708,0003.75%
EMORY UNIVERSITY 11,096$1,306,0003.64%
Atika Capital Management LLC 61,000$7,180,0003.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 488,912$57,550,0002.78%
Segantii Capital Management Ltd 100,000$11,134,0002.55%
NEXT CENTURY GROWTH INVESTORS LLC 428,835$50,478,0002.10%
View complete list of ANACOR PHARMACEUTICALS INC shareholders